!MediaMultimedia SeriesConferencesResourcesChoose SpecialtySpotlight -
!!
* !
!Choose Specialty!!
 !!
* + Spotlight
  + 
  + Media
  + Multimedia Series
  + Conferences
  + Resources
Advertisement
---
# Rheumatology
>Related Topics
!!!!
The *HCPLive* Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
## Latest News
 !!By 
January 23rd 2025
The lower BHI observed was likely associated with effects on the musculoskeletal system and not the central nervous system.
!!By 
January 22nd 2025
Infection and injury were the most common responsible diagnoses for patinets with both PsA or AS.
!! By 
January 21st 2025
Cancer risk was examined for breast, colorectal, lung, and prostate cancer.
A post-hoc analysis evaluated pooled data from 4 trials of pegloticase.
January 18th 2025
A study found frequent comorbidity between cluster headache, fibromyalgia, and migraine, as well as heightened depression and sleep disturbance among these individuals.
Video Series!!!!!!!!!!Video Interviews!.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30)!!!!!!!.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30)!!Podcasts!!!!!!!!!!Latest CME Events & Activities!!Case-based SimulationCME,NCPD
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More!!In-Person + Virtual EventCME
Internal Medicine Meeting
April 3, 2025
Register Now!!!VideoCME,NCPD
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More!!VideoCME,NCPD
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More!!Case-based SimulationCME
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More!!VideoCME
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More!!MultimediaCME
Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies
Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis
View More!!MultimediaCME,NCPD
Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
View More
## More News
!
By [January 17th 2025
Heat therapy often worsened symptoms in a randomized controlled trial.!
By !
By [January 15th 2025
A VR exergame may facilitate patients’ physical activity while promoting relaxation and positive mental states.!
By [January 14th 2025
Recommendations have been largely preserved since 2018 and the USPSTF acknowledged the need for more research and better risk assessment tools.!
By [January 13th 2025
However, gout flare states of patient acceptable symptom state, low disease activity, or not achieving either were not associated with EQ-5D-3L or HAQ.!
By [January 12th 2025
Investigators found an incidence of 26.2 severe infections per 100 patient-years with 4 deaths in the study.!
By [January 10th 2025
Small molecule drugs may help fill gaps in treatment with biologic therapies.!
Tocilizumab and other biological drugs were particularly efficacious in lowering overall hemostatic potential, mitigating blood clot risks.!
Around 37% of those had never used a bDMARD reached sustained DMARD-free remission at 5 years,!
By [January 8th 2025
Despite improvements in PROs and disease activity, no statistically significant changes have been seen on blood biomarker analysis.!
By [January 7th 2025
The rheumatology month in review emphasizes new research in PsA and on cardiovascular events in rheumatic disease.!
An active comparator study found that incident use of gabapentin was associated with lower rates of falls than duloxetine and similar rates of severe falls.!
By [January 4th 2025
Less than half of rheumatologists self-reported adhering to febuxostat and allopurinol dosing recommendations.!
By [January 3rd 2025
Other recent research presented at ACR 2024 found increased CVD risk with glucocorticosteroid use.!
By [January 2nd 2025
A recent study identified the prevalence of asymptomatic pulmonary involvement in patients with newly diagnosed RA or PsA, highlighting the need to reevaluate screening protocols.!
By 
[December 31st 2024
Cell therapy, particularly CAR-T, is expanding into autoimmune diseases like lupus and multiple sclerosis. While promising, safety, efficacy, and broad applicability remain uncertain.!
By [December 30th 2024
This year in review spotlights top rheumatology FDA news from 2024 and new research out of the ACR 2024 Convergence.!
By [December 24th 2024
After 16 weeks of treatment, a significantly greater proportion of deucravacitinib-treated patients achieved ACR20 response.!
By [December 21st 2024
A prospective study also found that the presence of psoriasis and dactylitis at disease onset were the strongest predictors for the development of PsA.!
By [December 19th 2024
These findings, from an observational study, should be confirmed in a randomized, controlled trial.!
By [December 17th 2024
The FDA has accepted the NDA for TNX-102 SL, a non-opioid, centrally acting analgesic, for the bedtime treatment of fibromyalgia; the PDUFA date still needs to be assigned.!
By [December 7th 2024
The rheumatology month in review emphasizes new data from ACR 2024 in lupus, gout, and fibromyalgia. and the Department of Health and Society at the University of Toronto Scarborough")! and the Department of Health and Society at the University of Toronto Scarborough")
By [December 5th 2024
Women who gave birth after infertility without receiving fertility treatments had an elevated risk of developing SARDs, such as lupus.!
By [December 4th 2024
CDC, NIH, and AMA recommend PEMs to be at a 6th-to-8th-grade reading level, while assessed materials were readable at high school or higher levels.!
By [December 3rd 2024
CT-P41 had similar rates of bone mineral density increases and adverse events in data presented at the ACR 2024 Convergence.!
The GLEAM trial is currently enrolling patients to receive SC291, with data expected in 2025. Biosimilar for Crohn’s, UC, Psoriasis, PsA")! Biosimilar for Crohn’s, UC, Psoriasis, PsA")
By [December 2nd 2024
Ustekinumab-kfce is planned for launch in February 2025 according to a previous settlement and license agreement with Janssen.!
By [Published: November 30th 2024 | Updated: November 30th 2024
Findings from PsABIOnd can help reassure clinicians of similar efficacy between treatment choices.!
By [November 28th 2024
At the highest dose levels, mean plasma urate levels remained below 6.0 mg/dL for up to 12 weeks....Contact Info
2 Commerce Drive
Cranbury, NJ 08512
609-716-7777
!!!© 2025 MJH Life Sciences
 All rights reserved.